Literature DB >> 20605566

Expression of HPV16 E5 produces enlarged nuclei and polyploidy through endoreplication.

Lulin Hu1, Tamara A Potapova, Shibo Li, Susannah Rankin, Gary J Gorbsky, Peter C Angeletti, Brian P Ceresa.   

Abstract

Anogenital cancers and head and neck cancers are causally associated with infection by high-risk human papillomavirus (HPV). The mechanism by which high-risk HPVs contribute to oncogenesis is poorly understood. HPV16 encodes three genes (HPV16 E5, E6, and E7) that can transform cells when expressed independently. HPV16 E6 and E7 have well-described roles causing genomic instability and unregulated cell cycle progression. The role of HPV16 E5 in cell transformation remains to be elucidated. Expression of HPV16 E5 results in enlarged, polyploid nuclei that are dependent on the level and duration of HPV16 E5 expression. Live cell imaging data indicate that these changes do not arise from cell-cell fusion or failed cytokinesis. The increase in nuclear size is a continual process that requires DNA synthesis. We conclude that HPV16 E5 produces polyploid cells by endoreplication. These findings provide insight into how HPV16 E5 can contribute to cell transformation. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20605566      PMCID: PMC2923234          DOI: 10.1016/j.virol.2010.06.025

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  43 in total

1.  The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms.

Authors:  Kirsten Kabsch; Angel Alonso
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 2.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

3.  The epidermal growth factor receptor (EGFR): role in corneal wound healing and homeostasis.

Authors:  Y Nakamura; C Sotozono; S Kinoshita
Journal:  Exp Eye Res       Date:  2001-05       Impact factor: 3.467

4.  E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UV B-irradiation-induced apoptosis.

Authors:  Benyue Zhang; Dan F Spandau; Ann Roman
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.

Authors:  M L Gillison; W M Koch; R B Capone; M Spafford; W H Westra; L Wu; M L Zahurak; R W Daniel; M Viglione; D E Symer; K V Shah; D Sidransky
Journal:  J Natl Cancer Inst       Date:  2000-05-03       Impact factor: 13.506

Review 6.  Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis.

Authors:  H zur Hausen
Journal:  J Natl Cancer Inst       Date:  2000-05-03       Impact factor: 13.506

7.  Quantitative role of the human papillomavirus type 16 E5 gene during the productive stage of the viral life cycle.

Authors:  Sybil M Genther; Stephanie Sterling; Stefan Duensing; Karl Münger; Carol Sattler; Paul F Lambert
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

8.  Codon optimization of the HPV-16 E5 gene enhances protein expression.

Authors:  Gary L Disbrow; Iruvanti Sunitha; Carl C Baker; John Hanover; Richard Schlegel
Journal:  Virology       Date:  2003-06-20       Impact factor: 3.616

9.  The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-gamma.

Authors:  Benyue Zhang; Ping Li; Exing Wang; Zacharie Brahmi; Kenneth W Dunn; Janice S Blum; Ann Roman
Journal:  Virology       Date:  2003-05-25       Impact factor: 3.616

10.  Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis.

Authors:  G M Clifford; J S Smith; M Plummer; N Muñoz; S Franceschi
Journal:  Br J Cancer       Date:  2003-01-13       Impact factor: 7.640

View more
  6 in total

Review 1.  Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value.

Authors:  Niladri Ganguly
Journal:  Cell Oncol (Dordr)       Date:  2012-01-20       Impact factor: 6.730

Review 2.  The E5 proteins.

Authors:  Daniel DiMaio; Lisa M Petti
Journal:  Virology       Date:  2013-05-31       Impact factor: 3.616

Review 3.  Papillomavirus E5: the smallest oncoprotein with many functions.

Authors:  Aldo Venuti; Francesca Paolini; Lubna Nasir; Annunziata Corteggio; Sante Roperto; Maria S Campo; Giuseppe Borzacchiello
Journal:  Mol Cancer       Date:  2011-11-11       Impact factor: 27.401

Review 4.  How Human Papillomavirus Replication and Immune Evasion Strategies Take Advantage of the Host DNA Damage Repair Machinery.

Authors:  Valentina Bordignon; Enea Gino Di Domenico; Elisabetta Trento; Giovanna D'Agosto; Ilaria Cavallo; Martina Pontone; Fulvia Pimpinelli; Luciano Mariani; Fabrizio Ensoli
Journal:  Viruses       Date:  2017-12-19       Impact factor: 5.048

Review 5.  The Interaction of Human Papillomavirus Infection and Prostaglandin E2 Signaling in Carcinogenesis: A Focus on Cervical Cancer Therapeutics.

Authors:  Janice García-Quiroz; Bismarck Vázquez-Almazán; Rocío García-Becerra; Lorenza Díaz; Euclides Avila
Journal:  Cells       Date:  2022-08-15       Impact factor: 7.666

6.  Human papillomavirus oncoproteins and apoptosis (Review).

Authors:  Peiyue Jiang; Ying Yue
Journal:  Exp Ther Med       Date:  2013-10-30       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.